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Neurodegeneration and cachectic dwarfism are 
cardinal symptoms of the autosomal recessive seg­
mental progeria Cockayne syndrome (CS; Nance 
and Berry, 1992). Average life expectancy is 12 yr; 
however, the phenotype shows substantial vari­
ation in severity. 80% of CS cases are caused by 
mutations in the group B gene (CSB), with the 
remaining 20% caused by mutations in CSA. CSB 
is involved in transcription­coupled nucleotide 
excision DNA repair (TC­NER; Anindya et al., 
2010) and has been proposed to carry out chro­
matin remodeling (Citterio et al., 2000), act as 
a transcription factor (Le May et al., 2010), and 
function as a co­regulator of base excision re­
pair (BER; Stevnsner et al., 2008).
The CSBm/m mouse displays a mild neuro­
logical phenotype, with an increased susceptibil­
ity to UV­induced cancer (van der Horst et al., 
1997). This hypersensitivity to UV is a hallmark 
of CSB­deficient cells in culture and is related to 
the lack of TC­NER. However, CSB­deficient 
cells are also sensitive to alkylating and oxidizing 
agents (Stevnsner et al., 2008) and display defec­
tive repair of the DNA lesions 8­oxoguanine 
(Dianov et al., 1999) and 8­hydroxyadenine 
(Tuo et al., 2002). Oxidative lesions, repaired by 
BER, are particularly pertinent because the 
accumulation of oxidized proteins, lipids, and/or 
nucleic acids have been proposed to be an 
underlying cause of aging (Balaban et al., 2005). 
Endogenous oxidizing radicals originate pre­
dominantly from the mitochondria, where the 
mitochondrial BER machinery acts as the pri­
mary protector. Recent findings indicate that 
CSB is present in the mitochondria, suggesting a 
role for CSB in mitochondrial DNA (mtDNA) 
repair (Aamann et al., 2010; Kamenisch et al., 
2010). We now report that CSB participates 
in mitochondrial maintenance by inducing 
CORRESPONDENCE  
Vilhelm A. Bohr: 
vbohr@nih.gov
Abbreviations used: 3­MA,  
3­methyladenine; BER, base 
excision repair; COX4, cyto­
chrome c oxidase subunit 4; CS, 
Cockayne syndrome; ERR­, 
estrogen­related receptor ; 
FCCP, carbonyl cyanide­p­
trifluoromethoxyphenyl­
hydrazone; HSMM, human 
skeletal muscle myotube; MDF, 
mouse dermal fibroblast; mPTP, 
membrane permeability transi­
tion pore; mtDNA, mitochon­
drial DNA; PGC­1, 
peroxisome proliferator­ 
activated receptor  co­activator 
1; ROS, reactive oxygen 
species; TFAM, transcription 
factor A, mitochondrial; 
TMRM, tetramethyl rhodamine 
methyl ester.
Cockayne syndrome group B protein prevents 
the accumulation of damaged mitochondria  
by promoting mitochondrial autophagy
Morten Scheibye-Knudsen,1 Mahesh Ramamoorthy,1 Peter Sykora,1  
Scott Maynard,4 Ping-Chang Lin,2 Robin K. Minor,3 David M. Wilson III,1 
Marcus Cooper,5 Richard Spencer,2 Rafael de Cabo,3 Deborah L. Croteau,1 
and Vilhelm A. Bohr1,4
1Laboratory of Molecular Gerontology, 2Magnetic Resonance Imaging and Spectroscopy Section, and 3Laboratory  
of Experimental Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
4Institute for Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, DK-1165 Copenhagen, Denmark
5Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA 01655
Cockayne syndrome (CS) is a devastating autosomal recessive disease characterized by neuro-
degeneration, cachexia, and accelerated aging. 80% of the cases are caused by mutations in 
the CS complementation group B (CSB) gene known to be involved in DNA repair and tran-
scription. Recent evidence indicates that CSB is present in mitochondria, where it associates 
with mitochondrial DNA (mtDNA). We report an increase in metabolism in the CSBm/m mouse 
model and CSB-deficient cells. Mitochondrial content is increased in CSB-deficient cells, 
whereas autophagy is down-regulated, presumably as a result of defects in the recruitment of 
P62 and mitochondrial ubiquitination. CSB-deficient cells show increased free radical 
production and an accumulation of damaged mitochondria. Accordingly, treatment with the 
autophagic stimulators lithium chloride or rapamycin reverses the bioenergetic phenotype of 
CSB-deficient cells. Our data imply that CSB acts as an mtDNA damage sensor, inducing 
mitochondrial autophagy in response to stress, and that pharmacological modulators of 
autophagy are potential treatment options for this accelerated aging phenotype.
© 2012 Scheibye-Knudsen et al. This article is distributed under the terms of 
an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first 
six months after the publication date (see http://www.rupress.org/terms). After 
six months it is available under a Creative Commons License (Attribution–
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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no histological changes were found in the CSBm/m mice 
(unpublished data), despite a trend toward increased plasma 
creatine kinase in the CSB­deficient mice (Table S1).
CSBm/m mice show increased metabolism
The observed fat loss could be the result of a decrease in food 
consumption, gastrointestinal malabsorption, or increased en­
ergy expenditure. Surprisingly, the old CSBm/m mice consumed 
33% more food than the age­matched WT mice (Fig. 2 A, 
n = 3). No steatorrhea was observed, and histology of the 
jejunum, ileum, and colon did not reveal pathology that could 
indicate malabsorption in the mutant animals (Fig. 2, B and C). 
We therefore investigated the overall metabolism of the mice. 
Housing the animals in metabolic cages revealed increased O2 
consumption and CO2 production without an increase in 
movement in the old CSBm/m mice (Fig. 2 D; movement data 
not depicted). Interestingly, there was a trend toward in­
creased respiratory exchange rates in the old CSBm/m mice, in­
dicating that the loss of fat was not the result of a preference 
for ­oxidation (Fig. 2 D). Serum chemistry showed no differ­
ence in blood glucose or cholesterol (Table S1); however, a de­
crease in circulating triglycerides was observed in old CSBm/m 
mice, reflecting the increased metabolism.
Intriguingly, by data­mining a previously published and 
validated microarray of mouse dermal fibroblasts (MDFs) 
from the CSBm/m animals (Garinis et al., 2009), we found a 
strong correlation between metabolism and CSB deficiency. 
When comparing the expression profiles of MDFs from WT 
and CSBm/m mice, we found 90 genes that were significantly 
differentially regulated (±1.5 SD, 32 genes down­ and 58 up­
regulated; Fig. S1 A). Interrogating the gene ontology terms 
in greater detail, we saw a clear increase in genes involved in 
energy metabolism in the CSB­deficient fibroblasts. All of 
the top 10 up­regulated gene ontology terms and a total of 
22 out of 94 up­regulated terms were ATP production re­
lated, indicating an attempt by the cells to up­regulate energy 
production (Fig. 2 E and Fig. S1 B). When examining the 
down­regulated gene ontology terms, the list is dominated 
by terms involved in protein synthesis, in accordance with 
previous literature of organisms under energy deprivation 
(Hansen et al., 2007).
Cellular metabolism is increased in CSB-deficient cultured cells
To explore if the hypermetabolic condition of the mouse was 
present at the cellular level, we investigated the respiration in 
various CSB­deficient cell lines. MDFs from young and old 
CSBm/m and WT mice, as well as fibroblasts derived from the 
CS patient CS1AN complemented with WT CSB or an empty 
vector, were examined. Additionally, we performed lentiviral 
knockdown of CSB in primary human myotubes (human skeletal 
muscle myotube [HSMM]). Finally, we also examined three 
primary CSB­deficient patient cell lines (GM739, GM1629, 
and GM2838) with age­ and gender­matched control lines 
(GM969, GM38, and GM8402, respectively). Oxygen con­
sumption and extracellular acidification were measured using 
the Seahorse XF24 analyzer. Every CSB­deficient cell line 
autophagy in response to mitochondrial stress. Lack of CSB 
leads to mitochondrial dysfunction and increased metabo­
lism, both at the organismal and cellular level. Accordingly, 
we show that pharmacological activation of autophagy re­
verses the bioenergetic profile. Based on this, we propose that 
CSB acts as a sensor of mtDNA damage and regulates mito­
chondrial autophagy and that treatment with rapamycin or 
lithium chloride could potentially attenuate some symptoms 
related to CS.
RESULTS
CSBm/m mice show age-related and universal loss of fat
Because mitochondrial dysfunction can have an effect on 
overall metabolism, we investigated the distribution and vol­
ume of adipose tissue, using T1­weighted MRI, in old and 
young WT and CSBm/m mice. The combined volume of the 
abdominal and epididymal fat depots in old CSBm/m mice was 
only 36% of the amount in old WT mice (Fig. 1 A). Interest­
ingly, this difference was already present in the young group, 
which showed 82% of the amount of fat compared with age­
matched controls. The loss of fat was not only subcutaneous 
but also visceral fat (Fig. 1 B and Video 1). Curiously, during 
the MRI scans the old CSBm/m mice were found to be par­
ticularly difficult to maintain at a constant respiration fre­
quency under anesthesia, as evident from the large fluctuations 
in respiration frequency (Fig. 1 C).
Skin histology of old CSBm/m mice also showed loss of 
subcutaneous fat by HE staining (Fig. 1 D) as previously 
reported (Kamenisch et al., 2010). Liver histology from the 
old WT mice, but not CSBm/m animals, showed vacuolization of 
the cytoplasm (Fig. 1 E) caused either by an accumulation 
of lipids or glycogen. Using periodic acid­Schiff staining, 
we found no difference in the amount of glycogen in the 
liver tissue (Fig. 1 F), indicating a decrease in liver lipids in 
old CSBm/m.
The CSBm/m mouse shows a CS-like phenotype
To further investigate a possible phenotype in the CSB­
deficient mice, we performed extensive histology, hematol­
ogy, and serology on young and old CSBm/m and WT mice. 
Table S1 shows a list of serum chemistry, hematology, and 
organ weights examined. The only overall significant difference 
uncovered when comparing the young WT and CSBm/m 
mice was an 50% increase in thymus weight (31 mg, WT vs. 
48 mg, CSBm/m; P = 0.03), indicating a delay in organ involu­
tion; however, no histological disparity was observed (unpub­
lished data).
For the old CSBm/m mice, subtle signs of neurodegenera­
tion were present. A substantial loss of spiral gangliocytes was 
found in the inner ear of the old CSBm/m mice (Fig. 1 G), 
consistent with the sensorineural hearing loss associated with 
CS (Nance and Berry, 1992). The CSBm/m mice displayed sig­
nificantly smaller brain weights compared with WT (Fig. 1 H), 
although the cerebrum, cerebellum, spinal cord, and ischiatic 
nerve showed no sign of pathology (unpublished data). Several 
mitochondrial diseases show skeletal or heart myopathy, yet 
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(FCCP)–uncoupled respiration was found to be increased 
in CSB­deficient CS1AN cells, myotubes, and MDFs from 
old CSBm/m mice (Fig. 3 C; CS1AN: n = 7, paired Student’s 
t test; HSMM: n = 3, paired Student’s t test; old MDF: n = 3, 
paired Student’s t test). An increase in FCCP­uncoupled res­
piration could be the result of an increased mitochondrial 
membrane potential. Indeed, we found a robust increase in 
tetramethyl rhodamine methyl ester (TMRM) staining by flow 
tested showed increased basal respiration, although only two cell 
lines reached significance when compared with the controls 
(GM38 vs. GM1629 and GM8402 vs. GM2838; n = 3, paired 
Student’s t test; Fig. 3 A). All the CSB­deficient cells that were 
compared with isogenic controls showed increased extracel­
lular acidification rates, reflecting not only an increase in oxygen 
consumption but also increased glycolysis (Fig. 3 B). Addi­
tionally, carbonyl cyanide­p­trifluoromethoxyphenylhydrazone 
Figure 1. The old CSBm/m mice show signs of neurodegeneration and universal loss of fat. (A) Quantification of adipose tissue using T1-weighted 
MRI in young (2 mo) and old (20 mo) WT and CSBm/m mice (n = 3; data are represented as mean ± SEM). (B) Representative axial T1-weighted MRI scans 
of the CSBm/m and WT mice. Yellow denotes fat. (C) Respiration rates of mice during the MRI scans. (D) HE staining of abdominal skin in young and old WT 
and CSBm/m mice. The bar denotes the subcutaneous fat layer (n = 3). (E) HE staining of the liver. (F) Periodic acid-Schiff staining of the liver of the  
20-mo-old mice with and without diastase to show glycogen content. (G) HE staining of the inner ear. The star denotes the spiral ganglion (n = 3).  
(H) Brain weight of WT and CSBm/m mice (n = 3; data are represented as mean ± SEM).
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Figure 2. CSB deficiency increases whole body metabolism. (A) 1 wk food intake CSBm/m compared with age-matched WT mice (n = 3; data are repre-
sented as mean ± SEM). (B and C) HE staining of the small (B) and large (C) intestines (n = 3). (D) Mice were placed in metabolic cages for 72 h. O2 consump-
tion and CO2 production were measured. D1= dark phase 1, L1 = light phase 1, etc. (n = 3–8; data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01;  
***, P < 0.001). (E) Gene ontology terms of a microarray comparing MDFs from WT and CSBm/m mice (n = 3–4; blue is down-regulated and red is up-regulated).
cytometry (Fig. 3 D). Additionally, we observed a large 
variation in membrane potential within the CSB­deficient 
cells, as evident by the broadened peak, perhaps reflecting 
a significantly more heterogeneous population of mito­
chondria in CSB. Remarkably, addition of cyclosporin A, 
which increased the membrane potential in the WT cells, 
did not affect the membrane potential in CSB­deficient 
CS1AN cells, indicating a decreased activity of the mem­
brane permeability transition pore (mPTP) in CSB­deficient 
cells (Fig. 3 D).
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Figure 3. CSB deficiency increases cellular metabolism. (A and B) Oxygen consumption rates (OCRd; A) and extracellular acidification rates (ECARd; B) 
were increased in CSB-deficient cells. CS1AN: CSB patient cell line expressing an empty vector or a vector containing WT CSB. HSMM: HSMMs  
expressing scrambled shRNA or shRNA targeted to CSB. MDF: MDFs isolated from young and old CSBm/m mice. Primary CSB patient fibroblasts (GM739, 
GM1629, and GM2838) and healthy age-/gender-matched controls (GM969, GM38, and GM 8402) are shown. Blue are cells expressing WT CSB. Red are CSB-
deficient cells (n = 3–7; data are represented as mean ± SEM). (C) FCCP-uncoupled respiration was measured by sequential addition of oligomycin (green 
background), FCCP (gray background), and antimycin A (yellow background; n = 3–7; data are represented as mean ± SEM). (D) Mitochondrial membrane 
potential in CS1AN cells measured by 20 nM TMRM staining and flow cytometry and its responsiveness to treatment with cyclosporin A (CsA). Inset: 
quantification of the response to cyclosporin A (n = 3; data are represented as mean ± SEM). (E) Growth curve of CS1AN cells expressing either an empty 
vector or WT CSB. (n = 3; data are represented as mean ± SEM). (F) Glucose concentration was measured in the media of CS1AN cells expressing WT CSB 
or an empty vector (n = 3; data are represented as mean ± SEM). (G) ATP consumption of CS1AN cells expressing WT CSB or an empty vector after inhibi-
tion of ATP production with 100 mM 2-deoxyglucose and 1 µM oligomycin. Inset: half-life of ATP (n = 3; data are represented as mean ± SEM).
In cultured cells, the main carbon donor for metabolism is 
glucose. To support the respiratory data, we monitored the glu­
cose concentration and number of CS1AN cells over 36 h. Cell 
number data were fitted to the exponential growth curve 
(y = y0 × ekX; WT CSB, r2 = 0.99; empty vector, r2 = 0.96). In­
terestingly, CSB­deficient cells showed a significantly slower 
growth rate and consumed around twofold more glucose than 
cells expressing WT CSB (Fig. 3, E [n = 3, F­test] and F [n = 3]). 
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CSB-deficient cultured cells show an increased 
mitochondrial content
We next explored if the increase in cellular metabolism 
was reflected by an increase in mitochondrial content. Citrate 
synthase is a marker for mitochondrial content (Holloszy 
et al., 1970) and CSB­deficient CS1AN cells showed an 
10% increase in citrate synthase activity compared with cells 
When measuring ATP levels, however, we found no difference 
between the CS1AN cells expressing WT CSB and the empty 
vector (unpublished data). Based on these observations, we would 
predict that the CSB­deficient cells would consume more ATP 
and, indeed, that is what we found when we monitored the ATP 
levels after inhibiting both glycolysis (using 2­deoxyglucose) and 
oxidative phosphorylation (using oligomycin; Fig. 3 G).
Figure 4. CSB-deficient cells show increased mitochondrial content and decreased mitochondrial biogenesis. (A) Citrate synthase activity in CS1AN 
cells expressing WT CSB or an empty vector or in MDF from young or old CSBm/m or WT mice or in HSMM expressing scrambled or CSB-specific shRNA  
(n = 3–5; data are represented as mean ± SEM). (B) Representative confocal image of CS1AN cells expressing WT CSB or an empty vector transfected with the 
mitochondrial RFP-tagged protein using organelle lights. (C) Quantification of the mitochondrial RFP signal normalized to cell number (n = 3; data are repre-
sented as mean ± SEM). (D) Representative flow cytometry experiment of CS1AN cells expressing WT CSB or empty vector treated with 50 nM MitoTracker 
green. Inset: quantification of the flow cytometry data (n = 3; data are represented as mean ± SEM). (E–H) Quantitative PCR analysis of genes involved in 
mitochondrial biogenesis in CS1AN cells expressing WT CSB or empty vector (E), MDFs from young (F) and old (G) mice, and HSMM subjected to lentiviral CSB 
knockdown (H). The inset in H shows efficiency of lentiviral shRNA knockdown of CSB (n = 3; data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01).
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flux as measured by LC3B levels after treatment with bafilo­
mycin A and chloroquine (unpublished data). To investigate if 
a defect in autophagy could be observed in the CSB­deficient 
mice, we investigated whether LC3 levels were altered in 
whole brain lysates. Correlating well with the defect being 
specifically mitochondrial, we found no change in LC3B levels 
between WT and CSB­deficient animals (unpublished data). 
Accordingly, we did not find any CSB­dependent difference 
in the accumulation of ubiquitinated protein in the mice. We 
did, however, observe an increase in ubiquitinated protein 
with age as previously described (Ohtsuka et al., 1995; unpub­
lished data). To corroborate our findings in the CSB­deficient 
cells, we transfected CS1AN cells expressing WT CSB or the 
empty vector with a plasmid encoding eGFP­tagged LC3. 
The amount of eGFP­LC3 foci correlates with the formation 
of autophagic vacuoles (Jackson et al., 2005) and, upon quan­
tification, we saw a significant decrease in foci formation in 
the CSB­deficient cells, indicating a decrease in autophagy 
(Fig. 5 C, n = 3). To investigate whether the autophagic vacu­
oles contained mitochondria, we performed confocal micros­
copy examining the colocalization of endogenous LC3B and 
mitochondrial cytochrome c oxidase subunit 4 (COX4). Inter­
estingly, when measuring the unbiased global Pearson’s co­
efficient we saw a significant increase in the colocalization of 
LC3B and mitochondria in the CSB­proficient cells in re­
sponse to rotenone treatment (Fig. 5 D). This data could indi­
cate a defect in the recruitment of factors that have been 
proposed to specifically induce mitochondrial degradation. 
Indeed, when measuring the colocalization between P62 and 
COX4 we saw a significant decrease in the global Pearson’s 
coefficient in the CSB­deficient cells (Fig. 5 E). Ubiquitina­
tion of proteins in the outer mitochondrial membrane have 
been suggested to selectively lead to the degradation of dam­
aged mitochondria (Geisler et al., 2010). Interestingly, when 
investigating this in the CS1AN cells we observed a decrease 
in colocalization of ubiquitin and COX4 in cells lacking CSB 
(Fig. 5 F). There was neither a difference in the amount of 
ubiquitin staining at base line nor in the amount after inhibi­
tion of autophagy by bafilomycin A, supporting the notion of 
normal autophagic flux in the CSB­deficient cells. To further 
corroborate these data, we performed electron microscopy on 
the CS1AN cell lines after 24 h of rotenone treatment. In 
agreement with the previous findings, the CSB­deficient 
CS1AN cells had an increased amount of damaged mito­
chondria both at baseline and after rotenone treatment com­
pared with cells expressing WT CSB. This suggested a failure 
to clear the damaged mitochondria (Fig. 6, A and B). When 
measuring the mean mitochondrial diameter, we found that 
the CSB­deficient cells displayed a much greater variation in 
mitochondrial width than those from WT, demonstrating a 
significantly more heterogeneous mitochondrial population 
(Fig. 6 C) correlating well with our TMRM staining. In addi­
tion, a subset of CSB­deficient cells showed an accumulation 
of hyperdense membranous material (Fig. 6 D) and formation 
of multiple lamellar mitochondrial cristae (onion formation), 
indicative of loss of mtDNA (Kukat et al., 2008) or altered 
expressing WT CSB (Fig. 4 A, n = 5). This increase was also 
found in HSMM subjected to CSB knockdown, yet failed to 
reach significance. To further investigate mitochondrial con­
tent, we transfected CS1AN cells expressing WT CSB or 
empty vector with RFP­tagged mitochondrial protein. Live 
cells were then imaged on a confocal microscope and z­stacks 
were quantified. Using this approach, CSB­deficient CS1AN 
cells showed a twofold increase in mitochondrial content 
(Fig. 4, B and C, n = 3). We substantiated these results by flow 
cytometry, observing a clear increase in MitoTracker green 
staining intensity in CSB­deficient CS1AN cells compared 
with cells expressing WT CSB (Fig. 4 D, n = 5).
The amount of mitochondria in a cell must be a balance 
between synthesis and destruction. We therefore evaluated if 
changes in mitochondrial biogenesis could account for the 
altered mitochondrial content and function. In cooperation 
with estrogen­related receptor  (ERR­), peroxisome 
proliferator­activated receptor  co­activator 1 (PGC­1) po­
tently stimulates mitochondrial biogenesis. Although young 
CSBm/m MDFs showed no changes in the gene expression 
of the transcriptional regulators ERR­, PGC­1, and 
transcription factor A, mitochondrial (TFAM), CSB­deficient 
CS1AN, and old CSBm/m MDFs revealed specific decreases 
in these factors (Fig. 4, E–G). In the CSB knockdown HSMM, 
we observed a decrease in ERR­, consistent with the 
other CSB­deficient cell lines. PGC­1 and TFAM, how­
ever, were increased in the knockdown myotubes (Fig. 4 H). 
The reason for this discrepancy is at present unclear, but 
perhaps the full phenotype of CSB deficiency has not de­
veloped in the HSMM during the 3 d that passed from 
shRNA transfection to RNA isolation. Considering the 
consistent mitochondrial phenotype we see both across 
species and cell types with no consistent changes in these 
transcription factors leads us to believe that biogenesis was 
not causal in the phenotype.
CSB-deficient cells show decreased autophagy  
and an accumulation of damaged mitochondria
The observation mentioned in the previous section prompted 
us to investigate if macro­autophagy (hereon autophagy), the 
primary degradation route of mitochondria (Levine and 
Kroemer, 2008), might be altered in CSB­deficient cells. 
Upon formation of autophagic vacuoles, cytosolic LC3B 
(isoform­I, LC3B­I) is cleaved and inserted into the autopha­
gic membrane (isoform­II, LC3B­II), allowing autophagy 
to be monitored by measuring the LC3B­II/LC3B­I ratio 
(Levine and Kroemer, 2008). Previous literature has shown 
that the mitochondrial toxicant rotenone induces autophagy 
(Chen et al., 2007). Remarkably, we saw a significant defect in 
rotenone­induced autophagy in CSB­deficient CS1AN cells 
and HSMM after 24 h of treatment (Fig. 5, A and B; CS1AN, 
n = 3; HSMM, n = 2–5). Even basal autophagy was decreased 
in the CSB­deficient HSMM. Interestingly, treatment with 
ethidium bromide did not increase the LC3II/LC3I ratio, in­
dicating that mtDNA replication is independent of autophagy. 
This difference was not the result of a change in autophagic 
862 CSB drives mitochondrial autophagy | Scheibye-Knudsen et al.
Figure 5. Mitochondrial autophagy is decreased in CSB-deficient cells. (A and B) Western blots of CS1AN cells expressing WT CSB or an empty vec-
tor (A) or HSMM subjected to lentiviral knockdown of CSB treated with vehicle, 5 µM rotenone (autophagy inducer), or 500 ng/ml ethidium bromide for 24 h 
(B; n = 3, data are represented as mean ± SEM). (C) Representative image of CS1AN cells expressing WT CSB or an empty vector transfected with eGFP-
tagged LC3 and quantification of the foci per cell (n = 3; data are represented as mean ± SEM). (D) Representative image of CS1AN cells expressing WT CSB 
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DISCUSSION
We describe herein a dramatic age­
related fat loss in the CSBm/m mouse. 
We show that this phenotype is caused 
by an increase in baseline metabolism, as seen by increased 
food intake and increased oxygen consumption. On the cellular 
level, CSB deficiency led to increased oxygen consumption, 
hyperpolarized mitochondria, and increased mitochondrial 
volume that does not seem to be explained by increased mito­
chondrial biogenesis. The elevated mitochondrial metabolism 
appears to instead stem from decreased mitochondrial degra­
dation. Indeed, we find defective autophagy in CSB­deficient 
cells in response to mitochondrial stress, possibly caused by a 
defect in the recruitment of P62 to mitochondria as well as 
decreased mitochondrial ubiquitination. Consistent with an 
accumulation of damaged mitochondria, free radical forma­
tion is also increased in the CSB­deficient cells. Remarkably, 
using pharmacological activators of autophagy we are able to 
revert the bioenergetic profile of the CSB­deficient cells, 
indicating a possible treatment for this disease.
Based on our findings, we propose the following model. 
CSB localizes to the mitochondria and interacts with the nucle­
oid, especially under conditions of oxidative stress (Aamann 
et al., 2010; Kamenisch et al., 2010). We hypothesize that CSB 
plays a role as a sensor of mtDNA damage, either by directly 
binding to mtDNA or as an indirect signaling protein. DNA 
damage triggers a response, perhaps leading to the formation 
of the mPTP. Induction of the mPTP has been shown to signal 
complex five assembly (Paumard et al., 2002; Fig. 6 E). De­
creased autophagy could lead to an accumulation of damaged 
mitochondria and increased reactive oxygen species (ROS) 
production. Indeed, using dihydroethidium (Aykin­Burns 
et al., 2009) we found a significant increase in ROS forma­
tion in CSB­deficient CS1AN cells compared with cells 
expressing WT CSB (Fig. 6 F, n = 10).
Serum starvation, as well as the FDA­approved drugs rapa­
mycin and lithium chloride, is known to induce autophagy 
in cells. We therefore tested if these conditions could alter 
the bioenergetic profile of the CSB­deficient cells. Interest­
ingly, both starvation and rapamycin were able to decrease 
the mitochondrial content in CSB­deficient cells (Fig. 7 A). 
Furthermore, by treating the CSB­deficient cells with rapa­
mycin for 24 h we were able to decrease the membrane po­
tential in CSB­deficient cells, whereas inhibiting autophagy 
using 3­methyladenine (3­MA) led to an increase in mem­
brane potential only in the cell expressing WT CSB (Fig. 7 B). 
Finally, using the Seahorse XF24 analyzer we found that treat­
ment with either rapamycin or lithium chloride led to a de­
crease in FCCP­uncoupled respiration in the CSB­deficient 
cells, whereas treatment with 3­MA led to an increase in 
FCCP­uncoupled respiration essentially phenocopying the 
CSB­deficient cells (Fig. 7 C).
or an empty vector treated with vehicle or rotenone and stained for LC3B and COX4 (mitochondria; bars, 50 µm) and quantification of the Pearson’s co-
efficient of these cells (n = 4; data are represented as mean ± SEM). (E) Representative image of CS1AN cells expressing WT CSB or an empty vector treated 
with vehicle or rotenone and stained for P62 and COX4 (bars, 50 µm) and the quantification of the Pearson’s coefficient of these cells (n = 4; data are rep-
resented as mean ± SEM). (F) Representative image of CS1AN cells expressing WT CSB or an empty vector treated with vehicle or bafilomycin A and stained 
for ubiquitin and COX4 (bars, 50 µm) and the quantification of the Pearson’s coefficient of these cells (n = 4; data are represented as mean ± SEM).
 
Figure 6. CSB-deficient cells show ac-
cumulation of damaged mitochondria.  
(A) Representative electron microscopy im-
ages of CS1AN cells lines after treatment 
with vehicle or 5 µM rotenone. Red dots 
denote swollen/damaged mitochondria  
(n = 12). (B) Quantification of damaged mito-
chondria in vehicle and rotenone-treated 
CS1AN cells expressing WT CSB or an empty 
vector (n = 12; data are represented as  
mean ± SEM). (C) Mitochondrial diameter in 
CS1AN cells expressing WT CSB or an empty 
vector after vehicle or rotenone treatment. 
Each point represents one mitochondria and 
cross bar represents mean ± SD. (D) Arrows 
marking hyperdense membranous material 
in CS1AN cells expressing an empty vector. 
(E) Arrows marking mitochondrial onion 
formation in CS1AN cells expressing an 
empty vector. (F) ROS formation measured 
by dihydroethidium in CS1AN cells express-
ing WT CSB or an empty vector (n = 10; data 
are represented as mean ± SD).
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repair but, presumably, also because of a defect 
in BER. Accordingly, this nuclear DNA repair 
defect could lead to increased poly ADP­ribose 
polymerase activation and, consequently, increased 
poly ADP ribosylation. This is a process with a 
high energy cost because: (a) loss of NAD+ leads 
to increased NADH/NAD+ and, thus, an inhibi­
tion of glycolysis/oxidative phosphorylation; and 
(b) NAD+ recycling costs two ATP molecules 
for every ADP­ribose moiety. An increase in en­
ergy expenditure, as we observe, could be coun­
tered by decreasing inner mitochondrial membrane 
uncoupling which will lead to more ATP produced 
per oxygen consumed. This would lead to an in­
creased membrane potential that would directly 
lead to increased ROS formation. The autophagic 
defect could be a consequence of increased mem­
brane potential because depolarization of the inner 
membrane is thought to lead to autophagy.
Previous studies have shown increased au­
tophagy in several models of longevity (Levine and 
Klionsky, 2004), and life extension by caloric re­
striction or daf­2­mutation in Caenorhabditis elegans 
is dependent on autophagy (Meléndez et al., 2003; 
Jia and Levine, 2007). mTOR is a master inhibitor of autophagy 
(Díaz­Troya et al., 2008), and mice treated with the mTOR 
inhibitor rapamycin show increased life span (Harrison et al., 
2009). Several autophagy gene (ATG) knockout mouse 
models display CS like phenotype. For example, the ATG5/ 
mouse shows normal embryonic development but early neo­
natal death, presumably from energy deprivation (Kuma et al., 
2004). Brain­specific knockout of ATG7 or ATG5 leads to 
neurodegeneration with loss of purkinje cells in the cerebellum 
(Hara et al., 2006; Komatsu et al., 2006). In humans, decreased 
autophagy has been implicated in several neurodegenera­
tive diseases (Martinez­Vicente and Cuervo, 2007), and in­
creased autophagy attenuates aspects of neurodegeneration 
(Chen et al., 2008; Rangaraju et al., 2009). Based on the evi­
dence that increased autophagy may lead to life extension and 
autophagy (Carreira et al., 2010). Accordingly, mtDNA damage 
will selectively induce degradation of damaged mitochondria. 
Interestingly, inhibition of the mPTP by cyclosporin A pro­
tects against ischemia­reperfusion injury (Gomez et al., 2009). 
Based on our model, we would therefore predict increased 
resistance to ischemia­reperfusion injury in CSB­deficient cells 
as the result of a decrease in overall induction of the mPTP. 
Indeed, increased survival after kidney artery clamping has re­
cently been reported in the CSBm/m mouse (Susa et al., 2009).
Although a direct role of CSB in mitochondrial maintenance 
through autophagy seems to be the simplest explanation, we 
could propose a connection to some of the characterized func­
tions of CSB. It is well known that nuclear DNA damage accu­
mulates in cells and tissues deficient in CSB not only as a result 
of the nucleotide excision repair defect in transcription­coupled 
Figure 7. Rapamycin rescues the bioenergetic profile 
of CSB-deficient cells. (A) Mitochondrial content of 
CS1AN cells expressing WT CSB (left) or an empty vector 
(right) was measured using flow cytometry and 50 nM 
MitoTracker green staining after treatment with the autoph-
agy inducer 1 µM rapamycin (rapa), serum starvation 
(starve), or 10 mM of the autophagy inducer lithium chloride 
(LiCl; n = 3 representative experiments). (B) The membrane 
potential of CS1AN cells expressing WT CSB (left) or an 
empty vector (right) was measured using flow cytometry 
and 20 nM TMRM staining after treatment with 1 µM rapa-
mycin (rapa) or 10 mM of the autophagy inhibitor 3-MA 
for 24 h (n = 6 representative experiments). (C) The bio-
energetics profile of CS1AN cells expressing WT CSB or an 
empty vector after treatment with 10 mM lithium chloride, 
1 µM rapamycin, or 3-MA for 24 h (n = 3; data are repre-
sented as mean ± SEM).
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to CS, whereas a subset of cases of CoQ10 deficiency (Rötig 
et al., 2000), Leber’s hereditary optical atrophy (Funalot et al., 
2002), and chronic progressive external ophthalmoplegia 
(Zeviani et al., 1990) show overlapping phenotypical charac­
teristics. Additional evidence for a role of CSB outside nuclear 
DNA repair comes from the observation that CS patients do 
not show increased risk of cancer.
Currently, only palliative treatment is offered to CS patients, 
although one compound is currently under clinical trial (www 
.clinicaltrials.gov). Our study opens up the idea of stimulating 
autophagy as a potential therapeutic avenue. We show here 
that rapamycin reverses the bioenergetic profile of the CSB­
deficient cells. This compound is currently approved by the 
FDA and could be a natural choice, although the adverse 
effects are severe. Interestingly, the demyelination seen in CS 
has been related to microglial activation (Weidenheim et al., 
2009) and the immunosuppressant effect of rapamycin could, 
therefore, perhaps attenuate these symptoms as well. Lithium 
chloride is known to induce autophagy and could be another 
interesting treatment option. Besides the well known neuro­
protective properties of this drug, a common adverse effect 
is weight gain (Grandjean and Aubry, 2009), which would 
benefit these patients as well. A different strategy could be to 
target downstream effects of the mitochondrial dysfunction. 
Antioxidants have shown little or even detrimental effect in 
long term population studies (Bjelakovic et al., 2008). How­
ever, they are used to treat stroke by attenuating ROS for­
mation during ischemia­reperfusion injury (Wilson and Gelb, 
2002) and could perhaps be beneficial to CS patients. A more 
pragmatic approach could be to increase food intake in these 
patients, perhaps lessening some symptoms. However, this 
could be a double­edged sword because increased caloric 
intake could decrease autophagy.
In closing, we have uncovered a new possible mechanism 
underlying CS. We propose a model for the disease that opens 
up new avenues of therapeutic remediation. However, the 
implications of this study extend beyond CS into basic cellu­
lar mechanisms and breathe new life into the mitochondrial 
theory of aging.
MATERIALS AND METHODS
Animals. Male homozygous CSBm/m mice were compared with sex­ and 
age­matched C57BL/6 mice. 2­mo­old (young group) or 20–24­mo­old 
(old group) mice were used. Mice were housed at the National Institute on 
Aging (NIA) under standard conditions and fed standard animal chow. All 
experiments were approved by the NIA Animal Care and Use Committee 
and performed in accordance with National Institutes of Health Guidelines 
for the Care and Use of Laboratory Animals (National Institutes of Health 
Publication 85­23, National Institutes of Health, Bethesda, MD). Food con­
sumption was determined by administering 100 g of standard chow to single­
housed animals and measuring the remaining amount 1 wk later.
MRI. Comparison of fat distribution was performed using magnetic resonance 
imaging (MRI). Mice (n = 3) were anesthetized with 1.5% isoflurane in O2 
administered via a face mask and were maintained at a body temperature 
of 36 ± 1°C during data acquisition. Respiration was monitored via an 
MR­Compatible monitoring and gating system (Model 1025; SA Instruments 
Inc.) responsive to thoracic excursion. During the experiment, isoflurane 
concentration was adjusted ±0.5% to maintain a respiration rate of 60–80/min. 
neuroprotection, we are speculating that a deficiency in autoph­
agy could lead to a premature aging phenotype such as CS. 
Interestingly, we do not observe any severe neurological pheno­
type in our CSB­deficient mice. As has been pointed out, 
mirroring human neurodegenerative diseases in other organ­
isms seems to be difficult (Jucker, 2010). The Parkinson’s dis­
ease models are particularly interesting because a defect in 
mitochondrial degradation has been proposed to underlie the 
human condition (Geisler et al., 2010). However, like the CSB 
mutant mouse, little phenotype is seen in transgenic mouse 
models of this disease (Hatano et al., 2009), suggesting that 
rodents may have redundant mitophagic pathways or display 
increased resistance to mitochondrial degradation defects.
According to our model, lack of CSB induces a stochastic 
accumulation of damaged mitochondria, increased oxygen 
consumption, and ROS production. Oxidative stress has been 
observed in several neurodegenerative diseases (Trushina and 
McMurray, 2007), providing a link between our findings of 
increased ROS production and decreased autophagy to the 
neuropathology seen in CS. These findings could also explain 
the accumulation of lesions found in mitochondria from 
CSB­deficient cells (Muftuoglu et al., 2009; Osenbroch et al., 
2009; Aamann et al., 2010; Kamenisch et al., 2010). The in­
creased oxygen and glucose consumption we observe indicates 
a state of cellular energy deprivation. The microarray analysis 
we present further corroborates this conclusion. Increased 
energy consumption could explain the cachexia seen in humans 
with this disease. Accordingly, a recent paper by Kamenisch 
et al. (2010) reported subcutaneous fat loss in aged CSBm/m 
mice and ascribed this to increased mitochondrial DNA dele­
tions. The increase in mitochondrial deletions is of particular 
interest because mtDNA deletions have been reported to stimu­
late autophagy (Prigione and Cortopassi, 2007). In agreement 
with our model, a deficiency in autophagy caused by loss of 
CSB would be predicted to lead to an accumulation of mito­
chondrial deletions.
In addition to the recent evidence of the presence of CSB 
in the mitochondria (Aamann et al., 2010; Kamenisch et al., 
2010), indirect evidence of a mitochondrial role of CSB comes 
from biochemical analysis. Berquist and Wilson (2009) showed 
that Ca2+ stimulates and Mg2+ inhibits the strand annealing 
activity of CSB. Interestingly, Ca2+ is believed to accumulate 
in mitochondria (Rizzuto and Pozzan, 2006), and several mito­
chondrial proteins are activated by Ca2+ and inhibited by Mg2+ 
(Panov and Scarpa, 1996). Further evidence comes from our 
observation that old CSBm/m mice were difficult to maintain 
at stable respiration rates under isoflurane anesthesia. Increased 
ROS production and decreased mitochondrial respiration are 
observed after inhalation anesthesia (Stowe and Kevin, 2004). 
It seems likely that an underlying mitochondrial dysfunction 
would be aggravated by the exposure to isoflurane. Further sup­
port for a mitochondrial involvement in CS is the considerable 
similarity of the phenotype to mitochondrial diseases. Mito­
chondrial neurogastrointestinal encephalomyopathy (Nishino 
et al., 1999), Leigh syndrome (Finsterer, 2008), and NARP 
syndrome (Gelfand et al., 2011) bear substantial resemblance 
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10% FBS, 1% pen­strep, and 400 µg/ml geneticin and grown in 20% O2/ 
5% CO2 at 37°C. Primary human skeletal muscle myoblasts (HSMM; Lonza) 
were cultured in SkGM­2 medium (Lonza) according to company protocols 
in humidified 20% O2/5% CO2 at 37°C. To differentiate myoblasts into myo­
tubes, the medium was switched to DME:F­12 (Lonza) supplemented with 
3% fetal horse serum. Only passage five fully differentiated myotubes were 
used in experiments. HEK293T cells (American Type Culture Collection) 
were grown in DME supplemented with 10% Hyclone FBS (Thermo Fisher 
Scientific) at 37°C in 20% O2/5% CO2. Primary patient and control cells 
(Coriell Cell Repository) were grown in DME supplemented with 10% FBS, 
1% pen­strep. The use of the commercially available primary cell lines were 
conducted in accordance with the National Institutes of Health guidelines.
Whole cell extracts were produced by incubating cells in lysis buffer 
(LB; 50 mM Tris­HCL, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton 
X­100, and 1× protease inhibitor cocktail; Roche) for 30 min on ice. To 
ensure complete mitochondrial lysis, the lysate was subjected to sonication at 
5 W for 5 s, three times performed on ice. The extract was then cleared by 
centrifugation at 16,000 g for 10 min. Protein concentrations were measured 
using the Bradford assay with bovine serum albumin as a standard.
Isolation of MDFs. MDFs from old and young CSBm/m mice and WT age­
matched (n = 3) controls were isolated as follows: tail skin biopsies were 
minced using a scalpel, placed into a 35­mm dish with 1.5 ml complete medium 
(DME, 10% FBS, 100 U ml1 penicillin, 100 U ml1 streptomycin, and 
0.25 µg ml1 fungizone) and 1 ml collagenase solution (1,000 U ml1), and 
then incubated at 37°C in a 20% O2/5% CO2 incubator. After 24 h, the cells 
were triturated, passed through netting to remove large particles, and cen­
trifuged for 5 min at 200 g. The cell pellet was resuspended in 3 ml complete 
medium and transferred to a 25­cm2 flask and cultured to 90% confluency. 
At this point, 0.75 × 106 cells were subcultured into 75­cm2 flasks; this is 
considered passage 1. The cell culture was passaged at 0.75 × 106 cells per 
75­cm2 flask every 4–6 d. At passage 3, cells were harvested and frozen in 
10% DMSO, 70% FBS, and 20% DME and stored at 150°C. Upon thawing, 
cells were cultured in AmnioMAX II medium (Invitrogen) in humidified 
3% O2 and 5% CO2. All cells used for experiments were at passage 5.
Electron microscopy. Electron microscopy of CS1AN cells were performed 
by Electron Microscopy Bioservices. In brief, cells untreated or treated with 
5 µM rotenone for 24 h grown in 150 mm plates were fixed for 5 min at room 
temperature in 2.5% glutaraldehyde and 2% paraformaldehyde in Millonig’s 
buffer. Cells were then scraped, spun down, and allowed to fix for an additional 
2–3 h at 4°C. The cell pellet was washed twice carefully in Millonig’s buffer. 
The cell pellet was then minced post­fixed in 1.0% OsO4 and washed in ultra­
pure water. Samples were then en bloc stained with 2.0% aqueous uranyl ace­
tate, serially dehydrated in ethanol, embedded in Spurr’s plastic resin, and 
allowed to polymerize overnight at 70°C. Ultrathin 60–80­nm­thick sections 
were made using an ultramicrotome (UC7; Leica), mounted onto 200 mesh 
copper grids, and post­stained with uranyl acetate and Reynold’s lead citrate. 
Transmission electron microscopy was then performed on an electron micro­
scope (Tecnai Spirit Twin Transmission; FEI) at 80 kV. Images were quantified 
by counting the percentage of damaged mitochondria per image (n = 12–14) or 
by measuring the mitochondrial diameter using ImageJ (n > 100).
Lentivirus generation and infections. shRNA vectors against CSB were 
purchased from Santa Cruz Biotechnology, Inc. A cocktail of three vectors 
containing the following shRNA sequences were used: 5­GTCTTAC­
GAGATACCATAATTCAAGAGATTATGGTATCTCGTAAGACT­
TTTT­3, 5­CCAGAAGCAAGACAGTGAATTCAAGAGATTCA­
CTGTCTTGCTTCTGGTTTTT­3, and 5­GTCTTCCGAGAACTA­
TTGATTCAAGAGATCAATAGTTCTCGGAAGACTTTTT­3. As a 
control, a plasmid containing a scrambled shRNA was used (Plasmid­A; Santa 
Cruz Biotechnology, Inc.). Lentiviral production was done by co­transfection 
of pCMV delta R8.2 (plasmid 12263 deposited by Didier Trono, Addgene Inc.) 
backbone, pCMV­VSV­G (plasmid 8454, deposited by Robert Weinberg, 
Addgene Inc.), and the vectors expressing the shRNA into 293T cells by 
Imaging was performed on a 9.4T/105­mm Avance III spectrometer (Bruker 
BioSpin Corp.) using a 30­mm MicroMouse 2.5 imaging probe for the young 
mouse group, and a 7T/30­cm Bruker spectrometer using a 72­mm inner di­
ameter whole body resonator for the old mouse group. Multi­slice axial and 
coronal images were acquired using a moderately T1­weighted spin echo se­
quence. MRI parameters included TE/TR = 25 ms /500 ms, NEX = 2, FOV = 
5.0 × 5.0 cm (axial imaging) or 6.0 × 5.0 cm (coronal imaging), slice thickness = 
1.0 mm, and matrix size 256 × 128 for both mouse groups. Adipose tissue was 
quantified using ImageJ (Abrámoff et al., 2004) within each slice of the stacked 
images to permit measurement of the abdominal adipose tissue volume.
Serology, hematology, and histopathology. Mice (n = 3) were anesthe­
tized, weighed, and bled. Blood from each mouse was processed into anti­
coagulated whole blood and sera for hematology evaluation (HV 1700; Drew 
Scientific) and serum chemistry evaluation (Vet/Ace 39–10700­14; Alfawas­
sermann), respectively. After phlebotomy, mice were euthanized with CO2, 
necropsied, organs weighed, and tissues (adrenal gland, bladder, cerebellum, 
cerebrum, colon, ductus deferens, esophagus, epididymis, femur bone marrow, 
heart, liver, inner ear, ischiatic nerve, kidney, knee joints, lens, lung, lymph 
nodes, pancreas, pituitary, prostate, retina, skeletal muscle, skin, skull, sinuses, 
small/large intestines, spinal cord, spleen, stomach, testis, thymus, thyroid, 
parathyroid, and trachea) collected for histopathologic evaluation. The tissues 
were fixed in 10% neutral­buffered formalin for a minimum of 48 h before 
paraffin embedding. Paraffin­embedded tissues were sectioned 5 µm thick, 
placed on glass slides, and stained with hematoxylin and eosin for histopathologic 
evaluation by a veterinary pathologist.
Metabolic and physical activity. Metabolic rate of the mice (n = 3–8) was 
assessed by indirect calorimetry in open­circuit oxymax chambers using the 
Comprehensive Laboratory Animal Monitoring System (CLAMS; Columbus 
Instruments). Mice were single housed and maintained at 24°C under a 
12/12­h light/dark cycle (light period 0600–1800). Water and food were 
available ad libitum. All mice were acclimatized to monitoring cages for 3–6 h, 
after which twice­hourly automated recordings of gas exchange were taken 
over the next 60 h. The concentrations of O2 and CO2 were monitored at the 
inlet and outlet of the sealed chambers to calculate respiration. The sensors 
were calibrated against a standard gas mix containing defined quantities of O2, 
CO2, and N2. Constant airflow (0.6 liter/min) was drawn through the cham­
ber and monitored by a mass­sensitive flow meter. Each chamber was mea­
sured for 30 s at 30­min intervals. Movement (both horizontal and vertical) 
was monitored by beams 0.5 in apart on horizontal and vertical planes provid­
ing a high­resolution grid covering the X, Y, and Z planes. Beam breaks rep­
resenting mouse movement were recorded in 30­s epochs. Mice were weighed 
before and after each trial. The respiratory exchange ratio (RER) is simply the 
ratio between the carbon dioxide production and the oxygen consumption.
Microarray. Gene expression of CSBm/m MDFs compared with WT from a 
previously published microarray (E­MEXP­1968; ArrayExpress) was performed. 
Raw hybridization intensity data were log­transformed and normalized to yield 
z­scores. One dataset was found to be an outlier by scatter plot, sample clustering, 
and principal component analysis (Fig. S1, C–E) and was excluded from further 
analysis. The z­ratio was calculated as the difference between the observed gene 
z­scores for the experimental and the control comparisons, and dividing by the 
SD associated with the distribution of these differences. Z­ratio values +2.0 or 
2.0 were chosen as cut­off values, defining increased and decreased expression, 
respectively. A complete set of 522 cellular pathways was obtained from the 
Molecular Signatures Database (MSigDB, Broad Institute, Massachusetts Institute 
of Technology, Cambridge, MA). The complete set was tested for gene set 
enrichment using parametric analysis of gene set enrichment. For each pathway 
z­score, a p­value was computed using JMP 6.0 software to test for the signifi­
cance of the z­score obtained. These tools were part of DIANE 1.0 (see http://
www.grc.nia.nih.gov/branches/rrb/dna/diane_software.pdf for information).
Cell culture. SV40­transformed CS1AN cells stably transfected with either 
CSB (WT CSB) or empty vector were cultured in DME supplemented with 
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synthase (Sigma­Aldrich). Transfection with RFP­tagged mitochondrial pro­
tein (Organelle Lights; Invitrogen) was further used to investigate the amount 
of mitochondria according to manufacturer’s protocol (n = 3). In brief, 105 cells 
were plated in glass­bottom 20­mm plates. The next day, cells were washed 
in PBS and 500 µl of the transduction solution was added. Cells were in­
cubated 2 h in 37°C before the transduction solution was removed and the 
enhancer solution was added. After 2 h of incubation at 37°C, the enhancer 
solution was removed and normal growth media was added. 24 h later, live 
cells were imaged at 40× on a confocal microscope (Eclipse TE­2000e; 
Nikon), with a 60 ms brightfield and 200 ms rfp exposure time. 0.2 µm 
z­stacks were used to image entire cells and, with an average of at least 25 cells 
per transfection, were used per replica experiment. Quantification was per­
formed by normalizing voxel count to cell number using the Volocity software 
(PerkinElmer). Mitochondrial content was additionally investigated using 
MitoTracker green FM (Invitrogen) as previously described (Pendergrass 
et al., 2004) with slight modification (n = 3). In brief, 0.75 × 106 CS1AN cells 
expressing WT CSB or empty vector were harvested by trypsin, washed, and 
resuspended in DME without phenol indicator (Invitrogen). Half the cells 
were then stained with 50 nM MitoTracker green FM for 30 min at 37°C. 
Cells were washed twice and resuspended in PBS before fluorescence was 
measured by a flow cytometer (C6). Unstained cells were used to gate for 
stained cells.
PCR. Total RNA was isolated from cells using Trizol reagent (Invitrogen) 
per the manufacturer’s protocol (n = 3). Reverse transcription reactions 
were performed using Iscript (Bio­Rad Laboratories). Primers were designed 
using the Primer Express 2.0 (Applied Biosystems). The sequences of prim­
ers are shown in Table S3. Real­time PCR was performed using SYBR 
green PCR mix (Applied Biosystems) with a primer concentration of 500 nM. 
Hypoxanthine phosphoribosyltransferase (HPRT) served as an internal con­
trol to normalize samples.
Western blots. Western blots were performed according to standard proce­
dure. 30–100 µg proteins per lane were used. Samples were analyzed using 
4–20% tris­glycine SDS­PAGE (Invitrogen). The following antibodies were 
used: rabbit anti­CSB (Santa Cruz Biotechnology, Inc.), rabbit anti­LC3B 
(Novus Biologicals), mouse anti­GAPDH (Santa Cruz Biotechnology, Inc.), 
rabbit anti­lamin A/C (Santa Cruz Biotechnology, Inc.), mouse anti­P62 
(Abcam), goat anti­COX4 (Santa Cruz Biotechnology, Inc.), and rabbit anti­
ubiquitin (Santa Cruz Biotechnology, Inc.). Secondary HRP­conjugated anti­
bodies and ECL plus (GE Healthcare) were used to visualize the protein 
bands on a Typhoon scanner. Quantification was performed using ImageQuant 
(GE Healthcare).
For autophagy, 1 × 106 CS1AN cells were plated in 100 mm dishes (n = 3). 
24 h later, cells were treated with vehicle, 5 µM rotenone, or 500 ng/ml 
ethidium bromide. Cells were incubated 24 h and harvested. Cells were 
lysed in LB. For HSMM, 10 × 105 myoblasts were plated in 100 mm dishes 
and differentiated as described. Lentiviral knockdown was performed and, 3 d 
later, cells were treated with vehicle, 5 µM rotenone, or 500 ng/ml ethidium 
bromide before they were harvested.
Microscopy. To investigate colocalization, 5 ×104 cells were plated in 4­well 
chamber slides and grown overnight. The next day, the media was changed 
and vehicle, 5 µM rotenone, or 100 nM bafilomycin was added. Cells were 
treated for 24 h before being fixed for 15 min in 3.7% paraformaldehyde in 
PBS. Cells were then washed before being permeabilized in 0.25% Triton 
X­100 for 10 min on ice. Subsequently, cells were washed in PBS and blocked 
overnight in PBS containing 5% FBS. Primary antibodies were added at a 
concentration of 1:100 and incubated for 1 h at 37°C. After being washed, 
secondary antibodies were added at 1:1,000 and incubated for 1 h at 37°C. 
Cells were then washed 6 × 10 min in PBS before being mounted in prolong 
antifade gold with DAPI (Invitrogen). Images were acquired at 60× on a con­
focal microscope (Eclipse TE­2000e), 50 ms brightfield, 300 ms exposure time 
for COX4 at 488 nm, and 900 ms exposure time for P62 or LC3B at 647 nm. 
Quantification was done by averaging the unbiased global Pearson’s coefficients 
Fugene 6 transfection as per manufacturer’s protocol (Roche). The media 
containing the virus was harvested after 48 h, filtered through 0.45­µm pore 
filter, flash frozen, and stored at 80°C. Cells were seeded at a density of 
2 × 105 in 10­cm plates, 24 h before the infection. For infection, the media 
was removed and the cells were washed once with PBS. The frozen virus 
was thawed quickly and added to the plates. The plates were rocked every 
15 min by hand and incubated at 37°C for 2 h. Fresh media was sub­
sequently added.
Cellular oxygen consumption. Oxygen consumption and extracellular 
acidification rate measurements were performed using the Seahorse XF­24 in­
strument (Seahorse Biosciences). Cells were seeded into a Seahorse tissue cul­
ture plate at a density according to Table S1, and 16 h later media was changed 
to unbuffered XF assay media at pH 7.4 (Seahorse Biosciences), supplemented 
with 25 mM glucose (Sigma­Aldrich), 1 mM sodium­pyruvate, and 1 mM 
glutamax (Invitrogen). Cells were incubated for 1 h at 37°C at ambient O2 and 
CO2 concentration before measurements were taken. Respiration was mea­
sured in four blocks of 3 × 3 min. The first block measured the basal respira­
tion rate. Next, oligomycin (EMD) was added to inhibit complex V and the 
second block was measured. Then, FCCP (Sigma­Aldrich) was added to un­
couple respiration and the third block was measured. Finally, antimycin 
A (Sigma­Aldrich) was added to inhibit complex 3 and the last measurements 
were performed. See Table S2 for compound concentrations used. All com­
pound concentrations used had been optimized for that cell line. Immediately 
after finishing the measurements, cells were trypsinized and counted using a 
Coulter counter (Beckman Coulter). For HSMM, cells were plated in Sea­
horse tissue culture plates and allowed to grow to 90% confluency. The media 
was then changed to DME:F­12 (Lonza) supplemented with 3% fetal horse 
serum and the myoblasts were allowed to differentiate for 3 d. Lentiviral 
knockdown was then performed by addition of virus directly to each well. 3 d 
later, respiratory measurements were performed as described. After the experi­
ment, myotubes were lysed in LB, the protein content was measured, and res­
piration was normalized to protein concentration. Lysates were subsequently 
used for immunoblotting to investigate knockdown efficiency.
Mitochondrial membrane potential. In brief, 0.4 × 106 CS1AN cells 
expressing WT CSB or empty vector were harvested by trypsin, washed, and 
resuspended in DME without phenol indicator (Invitrogen). Cells were then 
stained with 20 nM TMRM for 15 min at 37°C with or without 1 µM 
cyclosporin A. Fluorescence was measured by a flow cytometer (C6; Accuri). 
Treatments with 10 mM lithium chloride (Sigma­Aldrich) or 1 µM rapamycin 
(Sigma­Aldrich) were done for 24 h before membrane potential.
Glucose consumption. Glucose consumption was measured by plating 
50,000 CS1AN cells expressing WT CSB or an empty vector in a 24­well 
dish (n = 3). 24 h later, media was changed to DME containing 10 mM glucose 
and supplemented with 1% pen­strep, 10% FBS, and 400 µg/ml geneticin. 
At the given time points, the glucose concentration was measured in the 
media using the GlucCell glucose monitoring system as per manufacturer’s 
instruction (Cesco Bioengineering). The cells were washed twice in PBS, 
trypsinized, and counted.
ATP concentration. In brief, 10,000 cells per well were plated in a 96­well 
dish. 24 h later, ATP levels were measured in using the ATPlite assay accord­
ing to manufacturer’s protocol (PerkinElmer). For the ATP consumption assay, 
100 mM 2­deoxyglucose and 1 µM oligomycin was added at time 0. Cells 
were subsequently lysed at the indicated time points and the ATP concentra­
tion was measured. Luminescence was measured on the 1450 MicroBeta Tri­
Lux Microplate Scintillation and Luminescence Counter (PerkinElmer).
Mitochondrial content. Citrate synthase activity (n = 3) was measured 
spectrophotometrically as described in Srere (1969) with modifications. Two 
different dilutions of the sample were loaded in duplicates into a 96­well dish. 
The linear increase in absorbance was measured at 412 nm over 5 min and 
the concentration was determined against a standard curve of purified citrate 
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of at least 10 unselected images per experiment using Volocity software. For 
live cell imaging of LC3B­eGFP, 105 cells were plated in glass­bottom 20­mm 
plates. The next day, cells were transfected with LC3­EGFP plasmid (plasmid 
11546, deposited by K. Kirkegaard, Addgene Inc.) using Fugene­6 trans­
fection according to the manufacturer’s protocol (Roche). 2 d later, live cell 
imaging was performed at 40× on a confocal microscope (Eclipse TE­2000e), 
with a 60 ms brightfield and 600 ms gfp exposure time. 0.2 µm z­stacks were 
used to image entire cells, and the means of at least 20 cells per transfection 
were used per replica experiment (n = 3). Quantification was performed by 
automatic unbiased spot finding using the Volocity software.
ROS production. The ROS marker dihydroethidium (DHE; Invitrogen) 
was used to measure intracellular ROS, predominantly superoxide (n = 10). 4 µM 
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and used to normalize the results.
Statistics. Prism 4.0 (GraphPad Software) was used to plot data, make 
graphs, and statistical analysis. Data are plotted as mean ± SEM. Unless other­
wise stated, two­tailed unpaired Student’s t test was performed.
Online supplemental material. Fig. S1 shows the list of genes significantly 
changed in the analyzed microarray as well as the quality control we per­
formed on the data. Video 1 shows a representative axial MRI scan of the 
young and old WT and CSBm/m mice. Table S1 shows serum chemistry, he­
matology, and organ weights of the old and young WT and CSBm/m mice. 
Table S2 shows a list of cells and compound concentrations used in the 
oxygen consumption experiments. Table S3 shows a list of primers used for 
quantitative PCR. Online supplemental material is available at http://www 
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